Moreover, patients with breast tumors exhibiting increased glucose uptake, as assessed by 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography (18FDG PET) scans, revealed reduced OVOL2 expression. This evidence concerns the gene OVOL2 and breast neoplasm.